Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy
Keratosis pilaris rubra successfully treated with topical sirolimus: Report of a case and review of the literature - Eckburg - 2022 - Pediatric Dermatology - Wiley Online Library
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial. - Abstract - Europe PMC
HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US
Learn more at www.HYFTOR.com
Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library
Home - HYFTOR® HCP Site
Example of a CMLM of the leg: the investigator will define two areas of... | Download Scientific Diagram
Study subject (a) prior to therapy and (b) following 6 months of... | Download Scientific Diagram
Figure 3 from Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex | Semantic Scholar
Home - HYFTOR® Patient Site
Sirolimus gel provides breakthrough treatment for TSC
New Breakthrough in Treatment for Rare Skin Condition - ResOU
About HYFTOR - HYFTOR® Patient Site
Hyftor Topical: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
Hepcvel Ayurvedic Sirolimus Tablets, for Anti-Infective, Gel
China Customized Sirolimus Topical Gel Reference Listed Drug Suppliers, Manufacturers - Factory Direct Price - TOSUN
Hyftor Topical Gel Now Available for TSC-Associated Facial Angiofibroma
Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up. - Abstract - Europe PMC
These highlights do not include all the information needed to use HYFTOR™ safely and effectively. See full prescribing information for HYFTOR. HYFTOR™ (sirolimus topical gel) Initial U.S. Approval: 1999
Sirolimus - Wikipedia
